勘误：面向放射科医生的乳腺癌新分期系统介绍：重点在于预后分期。
Erratum: Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage.
作者信息
Koh Jieun, Kim Min Jung
机构信息
Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.
Department of Radiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
出版信息
Korean J Radiol. 2022 May;23(5):570. doi: 10.3348/kjr.2022.0246.
Abstract
This corrects the article on p. 69 in vol. 20, PMID: 30627023.
摘要
这修正了第20卷第69页上的文章， PMID: 30627023。
相似文献
1
Erratum: Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage.勘误：面向放射科医生的乳腺癌新分期系统介绍：重点在于预后分期。
Korean J Radiol. 2022 May;23(5):570. doi: 10.3348/kjr.2022.0246.
2
ERRATUM.勘误
Int J Bioprint. 2020 Sep 17;6(4):309. doi: 10.18063/ijb.v6i4.309. eCollection 2020.
3
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
4
Corrigendum.勘误
J Indian Soc Periodontol. 2021 May-Jun;25(3):270. doi: 10.4103/0972-124X.315467.
5
Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage.为放射科医生引入新的乳腺癌分期系统：重点关注预后分期。
Korean J Radiol. 2019 Jan;20(1):69-82. doi: 10.3348/kjr.2018.0231. Epub 2018 Dec 27.
6
Erratum: Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy.勘误：用于预测无可触及淋巴结肿大的T1-2期浸润性乳腺癌患者N2或N3分期的列线图的开发。
J Breast Cancer. 2018 Jun;21(2):232. doi: 10.4048/jbc.2018.21.2.232. Epub 2018 Jun 20.
7
Erratum: ERRATUM.勘误：勘误。
Indian J Anaesth. 2011 Mar;55(2):121.
8
Erratum: ERRATUM.勘误：勘误。
Urol Ann. 2011 May;3(2):61.
9
Erratum: An Erratum to Correct Typographical Errors.勘误：一篇用于纠正排版错误的勘误。
Ann Rehabil Med. 2016 Oct;40(5):959. doi: 10.5535/arm.2016.40.5.959. Epub 2016 Oct 31.
10
Erratum: An Erratum to Correct Typographical Errors.勘误：一篇纠正排版错误的勘误。
Ann Rehabil Med. 2016 Dec;40(6):1151. doi: 10.5535/arm.2016.40.6.1151. Epub 2016 Dec 30.
引用本文的文献
1
miR-484 as an "OncomiR" in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes.作为乳腺癌中“致癌miRNA”的miR-484通过抑制凋亡基因促进肿瘤发生。
Ann Surg Oncol. 2025 Apr;32(4):2994-3008. doi: 10.1245/s10434-024-16656-0. Epub 2024 Dec 18.
Zotero 插件